Почетна › Остеосарком › Охајо
Kliničke studije za Остеосарком u državi Охајо
13 studija za Остеосарком traži učesnike na lokacijama u državi Охајо.
Gradovi u državi Охајо
Zvanični tekst studije (na engleskom)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 2
Узраст од 12 до 39 · Оба пола · Ажурирано 12. 11. 2026. · NCT04616560Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 1
12 Months – 20 Years · Оба пола · Ажурирано 8. 10. 2026. · NCT02013336Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
- UH Rainbow Babies & Children's Hospital, Cleveland
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05588648Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Nationwide Children's Hospital, Columbus
Тражи се учесникФаза 1/2
Узраст од 12 до 40 · Оба пола · Ажурирано 3. 9. 2026. · NCT07725380Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- и још 4
Тражи се учесникФаза 3
До 50 година · Оба пола · Ажурирано 25. 8. 2026. · NCT05235165SPEARHEAD-3 Pediatric Study
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 1/2
Узраст од 2 до 21 · Оба пола · Ажурирано 11. 8. 2026. · NCT05642455Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 6. 8. 2026. · NCT05210374Musculoskeletal Cancers Remote Monitoring and Care
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 6. 8. 2026. · NCT07129226NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 1/2
До 30 година · Оба пола · Ажурирано 3. 8. 2026. · NCT06239272Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 18. 5. 2026. · NCT01790152A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- The Ohio State University Wexner Medical Center, Columbus
Тражи се учесник
Узраст 13 и старији · Оба пола · Ажурирано 6. 2. 2026. · NCT06387485A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
Тражи се учесникФаза 2
18 Months – 40 Years · Оба пола · Ажурирано 12. 8. 2025. · NCT05135975Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.